These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 15375535

  • 21. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
    Choi J, Lim H, Nam DK, Kim HS, Cho DY, Yi JW, Kim HC, Cho YK, Kim MW, Joo HJ, Lee KB, Kim KB.
    Br J Cancer; 2001 Jan; 84(2):186-92. PubMed ID: 11161374
    [Abstract] [Full Text] [Related]

  • 22. Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival.
    Bathe OF, Franceschi D, Livingstone AS, Moffat FL, Tian E, Ardalan B.
    Cancer J Sci Am; 1999 Jan; 5(1):34-40. PubMed ID: 10188059
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
    Edler D, Kressner U, Ragnhammar P, Johnston PG, Magnusson I, Glimelius B, Påhlman L, Lindmark G, Blomgren H.
    Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
    [Abstract] [Full Text] [Related]

  • 24. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
    Jensen SA, Vainer B, Witton CJ, Jørgensen JT, Sørensen JB.
    Acta Oncol; 2008 Feb; 47(6):1054-61. PubMed ID: 18607850
    [Abstract] [Full Text] [Related]

  • 25. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.
    J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523
    [Abstract] [Full Text] [Related]

  • 26. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.
    Okumura K, Mekata E, Shiomi H, Naitoh H, Abe H, Endo Y, Kurumi Y, Tani T.
    Cancer Chemother Pharmacol; 2008 Apr 01; 61(4):587-94. PubMed ID: 17520254
    [Abstract] [Full Text] [Related]

  • 27. Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment.
    Trocha SD, Saha SS, Wiese D, Thompson J, Morton DL, Bilchik AJ.
    Am Surg; 2003 Oct 01; 69(10):918-22. PubMed ID: 14570375
    [Abstract] [Full Text] [Related]

  • 28. Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy.
    Santini D, Vincenzi B, Perrone G, Rabitti C, Borzomati D, Caricato M, La Cesa A, Grilli C, Verzì A, Coppola R, Tonini G.
    Oncology; 2004 Oct 01; 67(2):135-42. PubMed ID: 15539918
    [Abstract] [Full Text] [Related]

  • 29. Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors.
    Mini E, Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Tonelli F, Cortesini C, Capaccioli S, Ficari F, Quattrone A, Rossi S, Mazzei T.
    Oncol Res; 1999 Oct 01; 11(9):437-45. PubMed ID: 10821538
    [Abstract] [Full Text] [Related]

  • 30. Intratumoral induction of thymidylate synthase mRNA by 5-FU in colorectal cancer patients: association with survival.
    Tanaka-Nozaki M, Tajiri T, Tanaka N, Furukawa K, Takasaki H, Yoshimura K, Suzuki H, Naito Z, Sugizaki Y, Merk HF, Blömeke B, Kato S.
    Oncol Rep; 2003 Oct 01; 10(5):1425-9. PubMed ID: 12883718
    [Abstract] [Full Text] [Related]

  • 31. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil.
    Iacopetta B, Grieu F, Joseph D, Elsaleh H.
    Br J Cancer; 2001 Sep 14; 85(6):827-30. PubMed ID: 11556832
    [Abstract] [Full Text] [Related]

  • 32. Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients.
    Paradiso A, Simone G, Petroni S, Leone B, Vallejo C, Lacava J, Romero A, Machiavelli M, De Lena M, Allegra CJ, Johnston PG.
    Br J Cancer; 2000 Feb 14; 82(3):560-7. PubMed ID: 10682666
    [Abstract] [Full Text] [Related]

  • 33. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.
    Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, Iida S, Azuma M, Mori R, Omori A, Lenz HJ, Danenberg KD, Danenberg PV.
    Int J Oncol; 2008 Dec 14; 33(6):1257-62. PubMed ID: 19020759
    [Abstract] [Full Text] [Related]

  • 34. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C, Aust DE, Meyer W, Baretton GB, Schwabe W, Häusler P, Becker H, Liersch T.
    J Pathol; 2004 Dec 14; 204(5):562-8. PubMed ID: 15538739
    [Abstract] [Full Text] [Related]

  • 35. Immunohistochemical expression of thymidylate synthase as a prognostic factor and as a chemotherapeutic efficacy index in patients with colorectal carcinoma.
    Tachikawa D, Arima S, Futami K.
    Anticancer Res; 2000 Dec 14; 20(6A):4103-7. PubMed ID: 11131679
    [Abstract] [Full Text] [Related]

  • 36. Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer.
    Li Y, Li X, Dai H, Sun X, Li J, Yang F, Gu H, Yang Y, Jin Z, Chu Y, Jin X, Kakehi Y, Wu X.
    BJU Int; 2009 Feb 14; 103(4):547-52. PubMed ID: 18990150
    [Abstract] [Full Text] [Related]

  • 37. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
    Fernández-Contreras ME, Sánchez-Hernández JJ, González E, Herráez B, Domínguez I, Lozano M, García De Paredes ML, Muñoz A, Gamallo C.
    Int J Oncol; 2009 Jan 14; 34(1):219-29. PubMed ID: 19082493
    [Abstract] [Full Text] [Related]

  • 38. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
    Huang ZH, Hua D, Li LH.
    Cancer Chemother Pharmacol; 2009 Apr 14; 63(5):911-8. PubMed ID: 18704422
    [Abstract] [Full Text] [Related]

  • 39. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
    Berglund A, Edler D, Molin D, Nordlinder H, Graf W, Glimelius B.
    Anticancer Res; 2002 Apr 14; 22(6B):3653-9. PubMed ID: 12552972
    [Abstract] [Full Text] [Related]

  • 40. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
    Ren DN, Kim IY, Koh SB, Chang SJ, Eom M, Yi SY, Seong SH, Kim MD, Bronner MP, Cho MY.
    J Surg Oncol; 2009 Dec 01; 100(7):546-52. PubMed ID: 19722231
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.